Complement-Based Drug Development Summit leaderboard
  • Monday, October 12, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 356

FDA Approves Kite’s Tecartus as the First and Only Car T for Adults With Relapsed or Refractory…

Oct 4, 2021
Kite, a Gilead Company announced the U.S. Food and Drug Administration (FDA) has granted approval for Tecartus (brexucabtagene autoleucel) for the treatment of adult patients (18 years…
Read More...

Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR…

Oct 4, 2021
Takeda Pharmaceutical Company Limited and JCR Pharmaceuticals Co., Ltd. announced a geographically-focused exclusive collaboration and license agreement to commercialize JR-141 (INN:…
Read More...

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of…

Oct 4, 2021
Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine,…
Read More...

Exclusive Chair Interview released ahead of SMi’s Medical Wearables for Biosensors Virtual…

Sep 28, 2021
SMi Group reports: SMi’s Medical Wearables for Biosensors conference chair interview with Andreas Caduff from Digital Medicine Society released The inaugural virtual Medical…
Read More...

Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002

Sep 27, 2021
Transcenta Holding Limited, a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based…
Read More...

FDA Approves Repatha (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial…

Sep 24, 2021
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Repatha (evolocumab) as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C)-lowering…
Read More...

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with…

Sep 23, 2021
AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialisastion of the proprietary self-amplifying RNA (saRNA) therapeutics…
Read More...

Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for…

Sep 23, 2021
Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced it has expanded its research collaboration with Columbia University. The research collaboration…
Read More...

Phenomenex Announces the Release of New Biozen SEC Size Exclusion Chromatography Columns

Sep 23, 2021
Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the successful launch of NEW Biozen SEC Size Exclusion…
Read More...

AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process…

Sep 23, 2021
Singapore's cancer population may benefit from improved access to cutting-edge clinical trials through InSite Feasibility - Oncoshot's new digital platform that facilitates the…
Read More...
Previous 1 … 354 355 356 357 358 … 957 Next
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
10th IPF Summit
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
17th World ADC London
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
17th World ADC San Diego
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
  • CSL, Alentis Partner on $1.55B Kidney and Liver Drug
  • Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B
  • KymaThera Raises $80M to Advance PI3Kα Cancer Drug
  • Industry Leaders Explore the Future of RNA Therapeutics Beyond Splicing

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

AI, Structure Prediction and Advanced Computational Tools…

New Preclinical Data and Translational Advances Set to Take…

FDA, Health Canada & Leading Biopharma Organizations…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.